# Volcano Capital

> Volcano Capital is a VC fund in New York backing Medical and Health Care. See 5 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 5
- Last investment: Dec 2020
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/1455169/
- Website: http://www.volcanocap.com

Volcano Capital is a healthcare venture capital that provides funding and operational expertise to help entrepreneurs grow their healthcare businesses. It invests in health care companies across a variety of asset classes including venture capital, public equities, and debt. Volcano Capital was founded in 2009 and is headquartered in New York.

## Contacts

5 contacts available for Volcano Capital. Shizune tracks 4 team members at Volcano Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/volcano-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 80% |
| Health Care | 3 | 60% |
| Medical Device | 3 | 60% |
| Biotechnology | 2 | 40% |
| Sensor | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 40% |
| Funding Round | 2 | 40% |
| Series A | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 60% |
| China | 1 | 20% |
| Israel | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bryan Grulke | Partner | 0 | https://shizune.co/investors/profile/bryan-grulke |
| Douglas Wall | Managing Partner | 0 | https://shizune.co/investors/profile/douglas-wall |
| Mariana Gantus Wall | Managing Director | 0 | https://shizune.co/investors/profile/mariana-gantus-wall |
| Robert Rushenberg | Senior Associate | 0 | https://shizune.co/investors/profile/robert-rushenberg |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Health Biotech | Health Biotech is a mass spec research and development company. |  | Series B | Dec 23, 2020 |  |
| VisionSense | Visionsense develops novel visualization solutions that bring natural stereoscopic sight to minimally invasive surgery (MIS). With advanced sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D-HD resolution images and maneuvering flexibility through the smallest access diameters. Existing MinimallyInvasive Surgery (MIS) vision solutions provide 2D (monocular) images that lack depth perception. This restricts the surgeon’s perspective limiting the ability to perform advanced MIS procedures. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand eye coordination and the confidence to use advanced (articulating) surgical tools. | $8M |  | Apr 01, 2018 |  |
| MediQuire | MediQuire aims to transform the health of the Medicaid population by bringing together medical, behavioral, financial and social data and using advanced analytics to understand how to improve patient outcomes while reducing cost. | $4M | Series A | Apr 04, 2016 |  |
| Mercator MedSystems | Mercator MedSystems’ mission is to become a global leader in interventional, site-specific delivery of therapeutics that improve patient outcomes in vascular disease, oncology, and regenerative medicine.The 15th and 16th Centuries marked the beginning of the Age of Exploration, a time of bold action, vast territorial expansion and profoundintellectual discovery. Gerardus Mercator (1512-1594), a mathematician and cartographer, played a key role in these ventures. He was as important to navigation as Copernicus was to astronomy. He perfected a map projection that was the first to represent the spherical surface of the earth in two dimensions. The Mercator Projection effectively transformed navigation, making it possible for ships to deliver cargo safely to any port on the globe.Inspired by the spirit of our namesake, Mercator MedSystems has developed a medical technology that enables the safe and accurate delivery of therapies anywhere in the body, ranging from drugs for diseased blood vessels, to stem cells that regenerate ailing tissues and organs. We believe this breakthrough will allow the expansion of medical therapy and stimulate profound intellectual exploration into new treatments for disease.We invite you to explore our web site, our technology and products, and to follow our progress to a new world of therapeutic delivery. | $6.5M | Series B | May 30, 2013 |  |
| Hydrocision | HydroCision develops, manufactures, and markets fluidjet based surgical tools for minimally invasive spine surgery requirements. Its products include SpineJet HydroSurgery System that is used to ablate, cut, and remove targeted tissue for spinal procedures, Spinejet, water-based technology solutions for minimally invasive spine surgeryrequirements, SpineJet HydroDiscectomy Systems, which are used to remove tissue without the risk of thermal energy for minimally invasive discectomy procedures, and AlloJet, systems to prepare bone allografts. The company also provides customer care services. HydroCision, Inc. was formerly known as Surgijet Corporation and changed its name to HydroCision, Inc. in November 1996. The company was founded in 1994 and is headquartered in North Billerica, Massachusetts. |  |  | Sep 15, 2010 |  |

5 of 5 investments shown.

## Co-investors
- [Aphelion Capital](https://shizune.co/investors/profile/aphelion-capital) — VC Fund, 1 deal together
- [Bioventures Investors](https://shizune.co/investors/profile/bioventures-investors) — VC Fund, 1 deal together
- [Blueprint Health](https://shizune.co/investors/profile/blueprint-health-accelerator) — VC Fund, 1 deal together
- [Clayton Associates](https://shizune.co/investors/profile/clayton-associates) — VC Fund, 1 deal together
- [Crocker Capital](https://shizune.co/investors/profile/crocker-capital) — VC Fund, 1 deal together
- [FCA Venture Partners](https://shizune.co/investors/profile/fca-venture-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Israel](https://shizune.co/investors/medical-vc-funds-israel)

## FAQ

### What does Volcano Capital invest in?

Volcano Capital invests primarily in Medical, Health Care and Medical Device startups, most often at Series B and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Volcano Capital?

Public channels for Volcano Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Volcano Capital?

The team at Volcano Capital includes Bryan Grulke (Partner), Douglas Wall (Managing Partner) and Mariana Gantus Wall (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co